Capivasertib

Capivasertib

Capivasertib (AZD5363) is an orally active, potent pan-AKT inhibitor (IC50 = 3, 7, and 7 nM for Akt1, Akt2, and Akt3, respectively) that suppresses tumor cell proliferation, particularly in breast cancer and PIK3CA/PTEN-mutated cells. Reagent grade, for research use only.

Molecular structure of the compound BP-43630
    • Unit
    • Price
    • Qty
    • 25 MG
    • $120.00
    • 50 MG
    • $210.00
    • 100 MG
    • $320.00
    • 250 MG
    • $540.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire